Figure 5.
Validation cohort for PDL1/PDL2 high gene expression prognostic impact. (A) PFS and (B) OS according to PDL1/PDL2 gene expression status (assessed by RT-MLPSeq) in the independent Centre Henri Becquerel validation cohort (n = 40).
Validation cohort for PDL1/PDL2 high gene expression prognostic impact. (A) PFS and (B) OS according to PDL1/PDL2 gene expression status (assessed by RT-MLPSeq) in the independent Centre Henri Becquerel validation cohort (n = 40).
